Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.6 USD | -1.90% | -1.12% | +22.29% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |